Cargando…
Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin
BACKGROUND: COVID-19 patients are at increased risk of coagulopathy. This coagulopathy may be due to a severe pro-inflammatory state (cytokine storm) and/or by viral sepsis. This can sometimes lead to consumption coagulopathy and decreased platelet count, leading to increased risk of bleeding and ma...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678264/ http://dx.doi.org/10.1159/000518931 |
_version_ | 1784616294880903168 |
---|---|
author | Taleja, Hitesh Nair, Vipin Venugopal Yadav, Sunanda Venkatnarayanan, Raghavendra Roy, Nilanjan Rao, Pankaj |
author_facet | Taleja, Hitesh Nair, Vipin Venugopal Yadav, Sunanda Venkatnarayanan, Raghavendra Roy, Nilanjan Rao, Pankaj |
author_sort | Taleja, Hitesh |
collection | PubMed |
description | BACKGROUND: COVID-19 patients are at increased risk of coagulopathy. This coagulopathy may be due to a severe pro-inflammatory state (cytokine storm) and/or by viral sepsis. This can sometimes lead to consumption coagulopathy and decreased platelet count, leading to increased risk of bleeding and may manifest like hematomas in atypical locations. These bleeding manifestations may be spontaneous or can be induced by even minor trauma. CASES: It is a single-center retrospective analysis. Four patients with a confirmed diagnosis of COVID-19 depicting increased risk of bleeding manifestations were included. Patients in our study were managed as per guidelines recommended by the Ministry of Health and Family Welfare Directorate General of Health Services, Government of India. RESULTS: All patients were male. The mean age was 56 ± 18.64 years. One patient was managed conservatively with discontinuation of anticoagulants, volume resuscitation, and transfusion of blood products. Drainage with incision was done for 2 patients. One was managed with pigtail drainage. CONCLUSION: The effect of anticoagulants given in therapy and their varied presentations are discussed in this article. The article concludes that we need vigilant observation to identify this complication in the early period, resulting in successful management. |
format | Online Article Text |
id | pubmed-8678264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-86782642021-12-17 Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin Taleja, Hitesh Nair, Vipin Venugopal Yadav, Sunanda Venkatnarayanan, Raghavendra Roy, Nilanjan Rao, Pankaj Dubai Medical Journal Complementary Medicine − Case Report BACKGROUND: COVID-19 patients are at increased risk of coagulopathy. This coagulopathy may be due to a severe pro-inflammatory state (cytokine storm) and/or by viral sepsis. This can sometimes lead to consumption coagulopathy and decreased platelet count, leading to increased risk of bleeding and may manifest like hematomas in atypical locations. These bleeding manifestations may be spontaneous or can be induced by even minor trauma. CASES: It is a single-center retrospective analysis. Four patients with a confirmed diagnosis of COVID-19 depicting increased risk of bleeding manifestations were included. Patients in our study were managed as per guidelines recommended by the Ministry of Health and Family Welfare Directorate General of Health Services, Government of India. RESULTS: All patients were male. The mean age was 56 ± 18.64 years. One patient was managed conservatively with discontinuation of anticoagulants, volume resuscitation, and transfusion of blood products. Drainage with incision was done for 2 patients. One was managed with pigtail drainage. CONCLUSION: The effect of anticoagulants given in therapy and their varied presentations are discussed in this article. The article concludes that we need vigilant observation to identify this complication in the early period, resulting in successful management. S. Karger AG 2021-09-20 /pmc/articles/PMC8678264/ http://dx.doi.org/10.1159/000518931 Text en Copyright © 2021 by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. |
spellingShingle | Complementary Medicine − Case Report Taleja, Hitesh Nair, Vipin Venugopal Yadav, Sunanda Venkatnarayanan, Raghavendra Roy, Nilanjan Rao, Pankaj Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin |
title | Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin |
title_full | Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin |
title_fullStr | Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin |
title_full_unstemmed | Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin |
title_short | Spontaneous Hematomas in COVID-19 Patients on Low-Molecular-Weight Heparin |
title_sort | spontaneous hematomas in covid-19 patients on low-molecular-weight heparin |
topic | Complementary Medicine − Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678264/ http://dx.doi.org/10.1159/000518931 |
work_keys_str_mv | AT talejahitesh spontaneoushematomasincovid19patientsonlowmolecularweightheparin AT nairvipinvenugopal spontaneoushematomasincovid19patientsonlowmolecularweightheparin AT yadavsunanda spontaneoushematomasincovid19patientsonlowmolecularweightheparin AT venkatnarayananraghavendra spontaneoushematomasincovid19patientsonlowmolecularweightheparin AT roynilanjan spontaneoushematomasincovid19patientsonlowmolecularweightheparin AT raopankaj spontaneoushematomasincovid19patientsonlowmolecularweightheparin |